OverviewChartProfileKey statisticsFinancialsTechnicalNewsTraderScreen

Swedish Orphan Biovitrum AB/  SE0000872095  /

OMX Nordic
10/15/2024  5:29:35 PM Chg. - Volume Bid5:29:35 PM Ask5:29:35 PM Market Capitalization Dividend Y. P/E Ratio
296.20SEK - 430,590
Turnover: 123.54 mill.		 294.60Bid Size: 1,304 295.00Ask Size: 1,128 104.96 bill.SEK - 39.65
GlobeNewswire 8/8 Cartesian Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 8/1 ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
GlobeNewswire 7/30 ADC Therapeutics to Host Second Quarter 2024 Financial Results Conference Call on August 6, 2024
GlobeNewswire 7/1 ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
GlobeNewswire 6/27 ADC Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes
GlobeNewswire 6/3 ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
GlobeNewswire 5/30 ADC Therapeutics to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire 5/24 Sobi to present new myelofibrosis data at the ASCO 2024 Annual Meeting
GlobeNewswire 5/24 Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Act...
GlobeNewswire 5/15 ADC Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at ...
GlobeNewswire 5/9 ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference
GlobeNewswire 5/6 ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire 5/6 ADC Therapeutics Announces Initial Data from Investigator-Initiated Phase 2 Clinical Trial of ZYNLON...
GlobeNewswire 5/1 ADC Therapeutics to Host First Quarter 2024 Financial Results and Pipeline Update Conference Call on...
GlobeNewswire 4/4 ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination wit...
GlobeNewswire 4/3 ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024
GlobeNewswire 4/1 Autolus Therapeutics Announces Changes to its Board of Directors
GlobeNewswire 3/28 Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors
GlobeNewswire 3/13 ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business U...
GlobeNewswire 3/6 ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes Summit
GlobeNewswire 3/6 ADC Therapeutics to Host Fourth Quarter and Year-End 2023 Financial Results Conference Call on March...
GlobeNewswire 3/5 ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cance...
GlobeNewswire 1/4 ADC Therapeutics Regains Compliance with NYSE Continued Listing Standards
GlobeNewswire 1/4 ADC Therapeutics Provides Business Updates
GlobeNewswire 12/12/2023 ADC Therapeutics Announces Initial Results from Investigator-Initiated Phase 2 Clinical Trial Evalua...